{"name":"Eureka Therapeutics Inc.","slug":"eureka-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPN3pJWE5ES2szT1pwNUxtdU1CVURtZG14LW5VcmJwRENYVmR6OFZnNlpHSTZxczQ1TG1WM1JEb1JxaEJROXk0T2NtQXJrOW5Gb1RKRUZkUmxsMkJOaGwxbUFjM1VfaTZSNC1jV0ZrOHZJTzN3S283czNnMHNXVFBWUVB3VU1SQmVpX09XMlpiLXJNUW5hdUtQRHlWaw?oc=5","date":"2026-03-25","type":"trial","source":"openPR.com","summary":"Metastatic Hepatocellular Carcinoma Clinical Trial Pipeline - openPR.com","headline":"Metastatic Hepatocellular Carcinoma Clinical Trial Pipeline","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPb3I0V2dVQXFmcE9MX0VXWlg3YzhBQkYydlpKZjVsSXdtOUM3c2FnVEtZaHZoSjdDUmQ3TnNtaUpyNkVWc29xNDIzRElhRUdJWTJGSGNZSGs1d0J5WVNYb0ptTjRtTmhfNkxId0VmZ285RGFYaVJseFljZlZieUl4THgwUUZqNHZpSFNmV0lOWXpFLXItc3E1WFR3?oc=5","date":"2026-03-25","type":"trial","source":"openPR.com","summary":"Hepatic Tumor Clinical Trial Pipeline Shows Potential with Active Contributions from 75+ Key Companies | DelveInsight - openPR.com","headline":"Hepatic Tumor Clinical Trial Pipeline Shows Potential with Active Contributions from 75+ Key Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNeC1xTV9JMmNIcnQ4aHp3NzBVakdyVngxWUZESUx4b2ZRRi1pR3VwVFlxdGVZVEE4dzVDTlptSWhleXMtc0NJdnBvNFMyWXlCak1EMGloXzFhQWFmRm91M3ZfdXlNTHhiQlVxbzNEUmQ5ejdPYXE3djhxZm1aMl95MjFxem1Bbjk3NVZwZVc0ODVOREdNX1RN?oc=5","date":"2026-03-20","type":"trial","source":"openPR.com","summary":"Hepatic Tumor Clinical Trial Landscape Strengthens as 75+ - openPR.com","headline":"Hepatic Tumor Clinical Trial Landscape Strengthens as 75+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPTjFuanFnZ0lpampJc0hyMEJCNFVrWG5pYnotQ0FfNkt3ZHh0c3U1WGxNRDZRUzNVakJzUkdtWTBZa0dlRF9IX29jbW9xYWI0bm9ZdmtLWFVIdE5CRnUxa0hGNzJwclk5UFhZeldGdlRmcnQwRU5vMWFwdko4SEwxYUozbUkwN3NoNW9uTk9RVU1Oc1VTU0RKUWtlc1d4T1NmVUFWUA?oc=5","date":"2026-03-02","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Fast-Tracked by the FDA in February 2026 - Oncology News Central","headline":"Oncology Drugs Fast-Tracked by the FDA in February 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPbjVTcFhWRVZMRlhYdzZ3aVBOb3U3M2JiUVF3Ri1qZHhQeUlTeE1nTGxLTzV6eU1ZeHFUbWJkZDVyNVNIUmZKY0tEN193MkhJeWgxM2tXTmhRMjFsV2xHSWRsR3N6SURabmU0ZXdpc3J4NDZDMXlGejFJRnVEUFNMbXRLWi1tYWd5X2NfQnJBMnpmLVZLc1E?oc=5","date":"2026-02-03","type":"trial","source":"Yahoo Finance","summary":"Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB103 at the 2026 Tandem Meetings of ASTCT® & CIBMTR® - Yahoo Finance","headline":"Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB103 at the 2026 Tandem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNTVFWNlk5RG9HMmlJS1l6NmdmMEd1TndCdE5HaC1uNzZKRUxTMVZZMlVzNHotM2E5VTFwTXNGcWZLUzlHVDlhLWxGQW1sVjBZQlFJSndUOEpZdDVHYjJVMFZxT1RWcEd4bU5IVmMzNmdIWkEtYm5FbERkc3hLOFhHYU50VlByRl9rVXdTWk9nM0k0amNLbGh0ZjRsdzVRSWxDNTZXODB6OA?oc=5","date":"2025-12-23","type":"deal","source":"BioWorld News","summary":"Rectify Pharmaceuticals and Boehringer Ingelheim partner in CKD - BioWorld News","headline":"Rectify Pharmaceuticals and Boehringer Ingelheim partner in CKD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPRGdKaXRfVFdEcDVnTGdQRFd4NEVRejk5eTNwNXltMFJBZWlmTTlORk1tWWxPd3VmOW9rSDQ3OEE4dGU0M2wtTlF3cmNVS0RnY0o1WmpGNjl0RTltZDJiVmRVOXBjaVcyTDUwYXN2NmxnUDhUVTVsZzZESFB0SXkzX1c4cVVyZXN4ZURDT3FFaE1JV2sxcjc3S01fTll0Z1JSay0xZnBNd1l4ZTlwX2JUVGhTR1MydXl4UjNreklqYTB2bG9BZlZKQWRpbUlKamZ3REltc3ZFS3JpN01zTlFOT2NxNFFYdk01WTFBVGZ1UjltZWRPYktCOGdtVU9OZENMRERCXzZwOGNHaHI2U1ZQV1pwYkx4Q1hEWDFrZGQwZDdrT3FiUXpNckdhWm1PMnUzdWpsV3ktZzNUeWNC?oc=5","date":"2025-12-10","type":"pipeline","source":"PR Newswire UK","summary":"Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight - PR Newswire UK","headline":"Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Tr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPNTZuRnZRSTV4bHZqbWhkTG9udjlVVzFIbEhQT254dFZTT0xfeVZsZ05NLUxvcXRwVVdnQlVkWXdxWVBLN0poOXZwekxQQkxkRG96V08wZ3pwbzYzOW1ZVGlQakIybExMd3ltU3RWSVdMQS16bXJZdExCaGZHRTc1TnVZbXFQYnBZaC1nQ092Tk5UclBabm43bENTaXpZOWxnUFdJQ3p3OTctTG1yZXhMM0pTMEZScGhHc0dFeGw4VHQxSHVnUmFoTzFwdmJDVUNPeUJpVGhUNWdwdndzbXpRc2EwNUJPLWZfa1VpQ3N4dDVBbTFULTltZVNqZktmZDYtMGY3WHdleDcxS21QazdXN21NM1ZKdw?oc=5","date":"2025-11-03","type":"trial","source":"Business Wire","summary":"Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients - Business Wire","headline":"Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluabl","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNdEJHZnFuajdBMG5VR1hBN3NyOFA3dFllSmsyTU1PTDNja09DRG9hRGJJQXhpOWx0TFU2X0lNZ1N1YnpiM0lzdXByQzFCaTJiV1RJZUF0d1R5UjlaeUdNNHBTMXhYU1M2OGFTNkUzYTB5VjlEYVBtZ1hjenRPVEVUNzBzZTFNM3pxNGRfLXoxRkJUVmpYei1aTDNCOXAtNkRBZDJrR0ZXbms5alNrR3JmTnpEZnRubk9BcmNlXzFiOEJIdjJMR0x3a2R2UXVyZllkdnpWU01udV9RRV9sbEtYLW15bndQdTRHM3o5ZDFWdkRJdw?oc=5","date":"2025-03-19","type":"deal","source":"PR Newswire","summary":"Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T‑Cell Therapy Development - PR Newswire","headline":"Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T‑Cell Therapy Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxOR3hlYkxWaVpPeUhiTUh1RWx5N3pySm9aX09HcEhJTFd6d2EyUVo1YUxnckxUWE92S3RtbjNfYkRhVkVWbWlLM2p3Y3lTSVg0UGVmNkZlTWtzemtUZkRqUTR3YUpaSUZtd2FnRnFZOVVZbHVuemlKMFY3d3RaSjk3dXNtalBsbTdXRkpGWF9zZG05b3BHQWU0enRKSjhheHVsSXZqbUZReDZRWTBNeHVyYmJHNWd5UXE1dGNvX2xZYno2SFMxTWpfcmtWYnU3ZVVESV9rcEhtZUE1N2picTlBRWVWQXE2NURFRzNn?oc=5","date":"2024-10-03","type":"trial","source":"CGTLive®","summary":"First Patient Dosed Achieves Complete Response in Estrella Immunopharma’s Trial for CD19-Targeted T-cell Therapy EB103 in B-Cell Lymphomas - CGTLive®","headline":"First Patient Dosed Achieves Complete Response in Estrella Immunopharma’s Trial for CD19-Targeted T-cell Therapy EB103 i","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPeFlwQUhfd3VPWS1VU0VWbGowZnFYZDA4T1h6Uk1ucGtqd2Y0cVZ2T3doRmQwd2FEM1JWMUNESVN5OFFWRndKaG1PeXloODBkdjNmNEthTVhITkdZR2dtajJZSmptVVI1OXFYdTEwUnZNMl81LTgtQlI1X2RkcHE3ZHdNaHR4eFlaUEJrVUNmbFhXMHM4OWp2TktweFFMNEJWSXE2RVdUNlBFaUQwVTVfZng1M0dZaFdvSFdBd29OOHVtdXJFZVJVb2ZnSlp6ZFdfRWxVUHlSbHZCUG9kXzF5d01xY3NkRUk?oc=5","date":"2024-09-27","type":"pipeline","source":"BioSpace","summary":"Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells - BioSpace","headline":"Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}